Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



King's College London - Health: More than a medical matter





Cord blood stem cell clinical trial for hearing loss begins

13 February 2012

By Dr Rebecca Hill

Appeared in BioNews 644

US researchers have received approval to test whether cord blood stem cells could be used to reverse hearing loss in children.

The phase I clinical trial, the first cord blood trial to be given the go-ahead by the US Food and Drug Administration (FDA), will determine the safety of the treatment. The team from the Children's Memorial Hermann Hospital in Houston will recruit ten children, aged six weeks to 18 months, who developed hearing loss after birth.

In 2008 a European team used human cord blood stem cells to reverse a kind of hearing loss - called sensorineural hearing loss - in mice. Dr Samer Fakhri, the principal investigator for the clinical trial, told the Winnipeg Free Press that these animal studies had been successful; after only two months the mice's 'inner ear organization and structure were basically restored'.

The majority of sensorineural hearing loss in humans is due to damaged hair cells in part of the inner ear called the cochlea. They are responsible for picking up and transferring signals to the brain to interpret.

It is not known how the stem cells repaired the damaged tissue in the mice - it could be that they regenerate these hair cells or that they initiate the body's own repair mechanisms.

'Currently, the only treatment options for sensorineural hearing loss are hearing aids or cochlear implants. We hope that this study will open avenues to additional treatment options for hearing loss in children', said Dr Fakhri.

The therapy will use stem cells taken from the patients' own cord blood, which has been banked at birth. At the start of the study the patients will have a brain scan, as well as blood, hearing and speech tests. Follow-up will be over the course of a year, with tests at one, six and twelve months post-treatment and a brain scan at six months.

It is stressed that the trial is primarily to assess the safety of injecting the stem cells into the children, and other researchers are treating the trial with care.

'We're a long way from looking at the possible therapeutic value of this in terms of restoring some sort of hearing', Dr Robert Harrison, a director of the Hearing Foundation of Canada, told the Winnipeg Free Press. 'It's a very theoretical concept, and in my opinion it's not going to happen soon'.

The study is being funded by the Cord Blood Registry and will take place at separate medical institutions in Texas and Georgia.

'If both of them can reproduce the same results then I would say it has some validity to it', Dr Stephen Epstein, an otolaryngologist in Maryland who is not involved in the study, told the AFP. 'This is certainly a welcome, acceptable experiment, but it should be looked at with caution and time will tell'.

 

SOURCES & REFERENCES
Cord Blood Registry | 12 January 2012
 
Study looks at whether stem cells in cord blood might repair hearing loss in kids
Winnipeg Free Press | 09 February 2012
 
AFP | 08 February 2012
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

17 September 2012 - by Greg Ball 
Stem cells have been used to partially restore hearing in deaf gerbils through replacement of their auditory nerve cells... [Read More]

06 February 2012 - by Mary Yarwood 
The All Party Parliamentary Group (APPG) on Stem Cell Transplantation last week called for more facilities in the UK to increase the collection and banking of valuable cord blood.... [Read More]
16 January 2012 - by Ayesha Jadoon 
'Re-training' immune cells in people with type 1 diabetes reduces the amount of insulin they need to inject, according to a results from a small clinical trial... [Read More]
16 August 2010 - by Dr Helen Busby 
The possibilities presented by the storage or 'banking' of stem cells from umbilical cord blood after birth have attracted considerable public and media interest since the early part of this decade... [Read More]
28 May 2010 - by Rosemary Paxman 
Delaying the clamping of the umbilical cord after birth by several minutes could bring future health benefits to newborns, according to new research.... [Read More]
06 April 2009 - by Ailsa Stevens 
Scientists based at Sheffield University, UK, have successfully created human inner ear cells from fetal stem cells, according to a study published in the journal Stem Cells last week. The ability to replace damaged or abnormal inner ear cells, using ones grown in the lab, could in... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
RISK ASSESSMENT:
BREAST CANCER, PREDICTION AND SCREENING
FREE public event in central London, 6.30pm on Thursday 8 May 2014 - find out more HERE

DataLabel Supplying Printed Labels To The UK For Over 15 Years

ANNIVERSARY APPEAL
Please donate HERE, so that the Progress Educational Trust can continue throughout 2014 (and beyond) while keeping BioNews FREE for you to read

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation